Silence Therapeutics Plc (SLN) Initiated at Overweight as Analyst Highlights Sirna Pipeline Potential
Silence Therapeutics plc (SLN) Initiated at Overweight as Analyst Highlights siRNA Pipeline Potential We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Silence Therapeutics plc (NASDAQ:SLN) is one of the most promising st